Medtronic - Latest Generation Drug-eluting Coronary Stent System
Ronan Rogers, Senior R&D Director at Medtronic discusses the newest drug-eluting coronary stent, the Onyx Frontier™ drug-eluting stent (DES). Onyx Frontier DES includes an enhanced delivery system designed to improve deliverability and increase acute performance in the most challenging cases of patients with coronary artery disease.
Global New Product Development lead for Medtronic’s Coronary business and New Product Development lead for Medtronic Ireland’s Leadership team.
Co-lead for Medtronic Ireland’s Global Inclusion, Diversity and Engagement Initiative, and executive sponsor for Medtronic Ireland’s Pride and STEM Employee Resource
Ronan has worked in Medtronic for 19 years in New Product Development across a range of Cardiovascular areas, including Coronary, Hypertension, Cardiac Rhythm and Heart Failure, Peripheral Vascular and Structural Heart products.
Ronan spent 6 years at NUI, Galway, where he completed a degree in Mechanical Engineering and a Masters in Engineering Science.